| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10218529 | Journal of Infection | 2018 | 26 Pages |
Abstract
A 5-miRNA signature shows potential for development as a novel biomarker for TB disease with potential to predict response to treatment. The failure of all miRNA to return to baseline levels may reflect ongoing remodelling in the lung parenchyma that continues after completion of anti-TB therapy.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Simone E Barry, Magda Ellis, YuRong Yang, Guangyu Guan, Xiaolin Wang, Warwick J Britton, Bernadette M Saunders,